Journal of medicinal chemistry, 2017-01, Vol.60 (2), p.627-640
- Castanedo, Georgette M
- Blaquiere, Nicole
- Beresini, Maureen
- Bravo, Brandon
- Brightbill, Hans
- Chen, Jacob
- Cui, Hai-Feng
- Eigenbrot, Charles
- Everett, Christine
- Feng, Jianwen
- Godemann, Robert
- Gogol, Emily
- Hymowitz, Sarah
- Johnson, Adam
- Kayagaki, Nobuhiko
- Kohli, Pawan Bir
- Knüppel, Kathleen
- Kraemer, Joachim
- Krüger, Susan
- Loke, Pui
- McEwan, Paul
- Montalbetti, Christian
- Roberts, David A
- Smith, Myron
- Steinbacher, Stefan
- Sujatha-Bhaskar, Swathi
- Takahashi, Ryan
- Wang, Xiaolu
- Wu, Lawren C
- Zhang, Yamin
- Staben, Steven T
2017
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Castanedo, Georgette M
- Blaquiere, Nicole
- Beresini, Maureen
- Bravo, Brandon
- Brightbill, Hans
- Chen, Jacob
- Cui, Hai-Feng
- Eigenbrot, Charles
- Everett, Christine
- Feng, Jianwen
- Godemann, Robert
- Gogol, Emily
- Hymowitz, Sarah
- Johnson, Adam
- Kayagaki, Nobuhiko
- Kohli, Pawan Bir
- Knüppel, Kathleen
- Kraemer, Joachim
- Krüger, Susan
- Loke, Pui
- McEwan, Paul
- Montalbetti, Christian
- Roberts, David A
- Smith, Myron
- Steinbacher, Stefan
- Sujatha-Bhaskar, Swathi
- Takahashi, Ryan
- Wang, Xiaolu
- Wu, Lawren C
- Zhang, Yamin
- Staben, Steven T
- Titel
- Structure-Based Design of Tricyclic NF-κB Inducing Kinase (NIK) Inhibitors That Have High Selectivity over Phosphoinositide-3-kinase (PI3K)
- Ist Teil von
- Journal of medicinal chemistry, 2017-01, Vol.60 (2), p.627-640
- Ort / Verlag
- United States: American Chemical Society
- Erscheinungsjahr
- 2017
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- We report here structure-guided optimization of a novel series of NF-κB inducing kinase (NIK) inhibitors. Starting from a modestly potent, low molecular weight lead, activity was improved by designing a type 11/2 binding mode that accessed a back pocket past the methionine-471 gatekeeper. Divergent binding modes in NIK and PI3K were exploited to dampen PI3K inhibition while maintaining NIK inhibition within these series. Potent compounds were discovered that selectively inhibit the nuclear translocation of NF-κB2 (p52/REL-B) but not canonical NF-κB1 (REL-A/p50).
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0022-2623eISSN: 1520-4804DOI: 10.1021/acs.jmedchem.6b01363Titel-ID: cdi_proquest_miscellaneous_1852780143
- Format
- –
- Schlagworte
- Active Transport, Cell Nucleus, Animals, Binding Sites, Cell Nucleus - metabolism, Dogs, HEK293 Cells, HeLa Cells, Heterocyclic Compounds, 4 or More Rings - chemical synthesis, Heterocyclic Compounds, 4 or More Rings - chemistry, Heterocyclic Compounds, 4 or More Rings - pharmacology, Heterocyclic Compounds, Bridged-Ring - chemical synthesis, Heterocyclic Compounds, Bridged-Ring - chemistry, Heterocyclic Compounds, Bridged-Ring - pharmacology, Humans, Imidazoles - pharmacology, Isoxazoles - chemical synthesis, Isoxazoles - chemistry, Isoxazoles - pharmacology, Mice, NF-kappa B p50 Subunit - metabolism, NF-kappa B p52 Subunit - metabolism, NF-kappaB-Inducing Kinase, Oxazepines - chemical synthesis, Oxazepines - chemistry, Oxazepines - pharmacology, Oxazoles - chemical synthesis, Oxazoles - chemistry, Oxazoles - pharmacology, Phosphoinositide-3 Kinase Inhibitors, Protein Kinase Inhibitors - chemical synthesis, Protein Kinase Inhibitors - chemistry, Protein Kinase Inhibitors - pharmacology, Protein Serine-Threonine Kinases - antagonists & inhibitors, Signal Transduction - drug effects